Antiretroviral Therapy and Medical Management of HIV-Infected Children, A., National Pediatric and Family HIV Resource Center, N., Health Resources and Services Administration, H. and National Institutes of Health, N. (2003) Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. UNSPECIFIED. (Unpublished)
ihi_(43).pdf - Other
Available under License Creative Commons Attribution Non-commercial.
Although the pathogenesis of human immunodeficiency virus (HIV) infection and the general virologic and immunologic principles underlying the use of antiretroviral therapy are similar for all HIV-infected persons, there are unique considerations needed for HIV-infected infants, children, and adolescents, including; A acquisition of infection through perinatal exposure for many infected children, In utero, intrapartum, and/or postpartum neonatal exposure to zidovudine (ZDV) and other antiretroviral medications in most perinatally infected children, Requirement for use of HIV virologic tests to diagnose perinatal HIV infection in infants under age 15 to 18 months old, Age-specific differences in immunologic markers (i.e., CD4+ T cell count), Changes in pharmacokinetic parameters with age caused by the continuing development and maturation of organ systems involved in drug metabolism and clearance, Differences in the clinical and virologic manifestations of perinatal HIV infection secondary to the occurrence of primary infection in growing, immunologically immature persons, and Special considerations associated with adherence to antiretroviral treatment for infants, children and adolescents. This report addresses the pediatric-specific issues associated with antiretroviral treatment and provides guidelines to health care providers caring for infected infants, children, and adolescents. It is recognized that guidelines for antiretroviral use in pediatric patients are rapidly evolving. The Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children will review new data on an ongoing basis and provide regular updates to the guidelines.
|Keywords:||Antiretroviral Agents, HIV Infection, Infants, Intrapartum, postpartum, Neonatal, Health Care|
|Subjects:||HIV > Surveillance
HIV > Prevention
|Depositing User:||Mr Joseph Madata|
|Date Deposited:||04 Mar 2013 06:07|
|Last Modified:||04 Mar 2013 06:07|
Actions (login required)
Downloads per month over past year